Chronic Lymphocytic Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Chronic Lymphocytic Leukemia
  • During Venetoclax
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Birmingham, Alabama
  • +873 more
2022-04-05
Apr 5, 2022
S
Terminated
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
2022-04-04
Apr 4, 2022
O
Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CLIC-1901
  • Vancouver, British Columbia, Canada
  • +1 more
2022-03-26
Mar 26, 2022
N
Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
2022-04-04
Apr 4, 2022
A
Recruiting
  • Chronic Lymphocytic Leukemia
    • Irkutsk, Russian Federation
    • +12 more
    2022-03-25
    Mar 25, 2022
    W
    Withdrawn
    • Chronic Lymphocytic Leukemia
    • CLL/SLL
    • New York, New York
      Weill Cornell Medicine
    2022-03-25
    Mar 25, 2022
    P
    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    2022-04-02
    Apr 2, 2022
    U
    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
      • Bobigny, France
      • +8 more
      2022-03-23
      Mar 23, 2022
      T
      Recruiting
      • Acute Lymphoblastic Leukemia
      • +15 more
      • Hematopoietic Cell Transplantation
      • +7 more
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      2022-04-01
      Apr 1, 2022
      N
      Recruiting
      • Waldenstrom Macroglobulinemia
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-03-31
        Mar 31, 2022
        A
        Recruiting
        • Chronic Lymphocytic Leukemia
          • Irkutsk, Russian Federation
          • +5 more
          2022-03-30
          Mar 30, 2022
          K
          Recruiting
          • Diffuse Large B Cell Lymphoma
          • +2 more
          • Goshen, Indiana
          • +39 more
          2022-03-28
          Mar 28, 2022
          W
          Recruiting
          • Chronic Lymphocytic Leukemia
          • +2 more
          • New York, New York
            Weill Cornell Medicine
          2022-03-29
          Mar 29, 2022
          A
          Recruiting
          • Chronic Lymphocytic Leukemia
          • +2 more
          • Phoenix, Arizona
          • +30 more
          2022-03-28
          Mar 28, 2022
          I
          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • +2 more
          • Zanubrutinib, Fludarabine, cyclophosphamide and rituximab
          • Zanubrutinib, bendamustine, rituximab
          • Tianjin, Tianjin, China
            Institute of Hematology & Blood Diseases Hospital
          2022-03-18
          Mar 18, 2022
          M
          Active, not recruiting
          • Chronic Lymphocytic Leukemia
          • +5 more
          • Houston, Texas
            M D Anderson Cancer Center
          2022-03-15
          Mar 15, 2022
          B
          Recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • Bengbu, Anhui, China
          • +55 more
          2022-03-25
          Mar 25, 2022